Cargando…
A study of motivations and expectations of patients seen in phase 1 oncology clinics
BACKGROUND: To better inform clinical practice, this study was aimed at capturing patients' motivations for enrolling in phase 1 trials and at quantifying their expectations of the benefits, risks, and commitment associated with clinical trials and the impact of the initial consultation on thei...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111585/ https://www.ncbi.nlm.nih.gov/pubmed/27716902 http://dx.doi.org/10.1002/cncr.30235 |
_version_ | 1782467890731024384 |
---|---|
author | Dolly, Saoirse O. Kalaitzaki, Eleftheria Puglisi, Martina Stimpson, Sarah Hanwell, Janet Fandos, Sonia Serrano Stapleton, Sarah Ansari, Thushara Peckitt, Clare Kaye, Stan Lopez, Juanita Yap, Timothy A. van der Graaf, Winette de Bono, Johann Banerji, Udai |
author_facet | Dolly, Saoirse O. Kalaitzaki, Eleftheria Puglisi, Martina Stimpson, Sarah Hanwell, Janet Fandos, Sonia Serrano Stapleton, Sarah Ansari, Thushara Peckitt, Clare Kaye, Stan Lopez, Juanita Yap, Timothy A. van der Graaf, Winette de Bono, Johann Banerji, Udai |
author_sort | Dolly, Saoirse O. |
collection | PubMed |
description | BACKGROUND: To better inform clinical practice, this study was aimed at capturing patients' motivations for enrolling in phase 1 trials and at quantifying their expectations of the benefits, risks, and commitment associated with clinical trials and the impact of the initial consultation on their expectations. METHODS: This was a single‐center, prospective, quantitative study of newly referred adult patients considering their first phase 1 oncology trial. Participants completed questionnaires before they were seen and an abbreviated follow‐up version after their consultation. RESULTS: Questionnaires were completed by 396 (99%) and 301 (76%) before and after the clinic, respectively. Participants ranked the possibility of tumor shrinkage (84%) as the most important motivation for considering a phase 1 trial; this was followed by no alternative treatments (56%), their physician's recommendation (44%), and the fact that the research might benefit others (38%). When they were asked about the potential personal benefit, 43% predicted tumor shrinkage initially. After the consultation, this increased to 47%. Fourteen percent of patients expected a cure. When asked about risks, 71% of the participants expected moderate side effects. When asked about expectations of time commitments, a majority of patients did not anticipate weekly visits, although this was understood by 93% of patients after the consultation. Overall, patients were keen to consider trials and when asked before and after the consultation 72% and 84% were willing to enroll in studies, respectively. CONCLUSIONS: This study reports that more than 80% of patients enroll in early‐phase clinical oncology trials motivated by the potential of a clinical benefit, with approximately half expecting tumor shrinkage and approximately a tenth anticipating a cure. The typical phase 1 response rate is 4% to 20%, and this discrepancy exemplifies the challenges faced by patients and healthcare professionals during their interactions for phase 1 studies. Cancer 2016;122:3501–3508. © 2016 American Cancer Society |
format | Online Article Text |
id | pubmed-5111585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-51115852016-11-16 A study of motivations and expectations of patients seen in phase 1 oncology clinics Dolly, Saoirse O. Kalaitzaki, Eleftheria Puglisi, Martina Stimpson, Sarah Hanwell, Janet Fandos, Sonia Serrano Stapleton, Sarah Ansari, Thushara Peckitt, Clare Kaye, Stan Lopez, Juanita Yap, Timothy A. van der Graaf, Winette de Bono, Johann Banerji, Udai Cancer Original Articles BACKGROUND: To better inform clinical practice, this study was aimed at capturing patients' motivations for enrolling in phase 1 trials and at quantifying their expectations of the benefits, risks, and commitment associated with clinical trials and the impact of the initial consultation on their expectations. METHODS: This was a single‐center, prospective, quantitative study of newly referred adult patients considering their first phase 1 oncology trial. Participants completed questionnaires before they were seen and an abbreviated follow‐up version after their consultation. RESULTS: Questionnaires were completed by 396 (99%) and 301 (76%) before and after the clinic, respectively. Participants ranked the possibility of tumor shrinkage (84%) as the most important motivation for considering a phase 1 trial; this was followed by no alternative treatments (56%), their physician's recommendation (44%), and the fact that the research might benefit others (38%). When they were asked about the potential personal benefit, 43% predicted tumor shrinkage initially. After the consultation, this increased to 47%. Fourteen percent of patients expected a cure. When asked about risks, 71% of the participants expected moderate side effects. When asked about expectations of time commitments, a majority of patients did not anticipate weekly visits, although this was understood by 93% of patients after the consultation. Overall, patients were keen to consider trials and when asked before and after the consultation 72% and 84% were willing to enroll in studies, respectively. CONCLUSIONS: This study reports that more than 80% of patients enroll in early‐phase clinical oncology trials motivated by the potential of a clinical benefit, with approximately half expecting tumor shrinkage and approximately a tenth anticipating a cure. The typical phase 1 response rate is 4% to 20%, and this discrepancy exemplifies the challenges faced by patients and healthcare professionals during their interactions for phase 1 studies. Cancer 2016;122:3501–3508. © 2016 American Cancer Society John Wiley and Sons Inc. 2016-09-26 2016-11-15 /pmc/articles/PMC5111585/ /pubmed/27716902 http://dx.doi.org/10.1002/cncr.30235 Text en © 2016 The Authors. Cancer published by Wiley Periodicals, Inc. on behalf of American Cancer Society. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Dolly, Saoirse O. Kalaitzaki, Eleftheria Puglisi, Martina Stimpson, Sarah Hanwell, Janet Fandos, Sonia Serrano Stapleton, Sarah Ansari, Thushara Peckitt, Clare Kaye, Stan Lopez, Juanita Yap, Timothy A. van der Graaf, Winette de Bono, Johann Banerji, Udai A study of motivations and expectations of patients seen in phase 1 oncology clinics |
title | A study of motivations and expectations of patients seen in phase 1 oncology clinics |
title_full | A study of motivations and expectations of patients seen in phase 1 oncology clinics |
title_fullStr | A study of motivations and expectations of patients seen in phase 1 oncology clinics |
title_full_unstemmed | A study of motivations and expectations of patients seen in phase 1 oncology clinics |
title_short | A study of motivations and expectations of patients seen in phase 1 oncology clinics |
title_sort | study of motivations and expectations of patients seen in phase 1 oncology clinics |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111585/ https://www.ncbi.nlm.nih.gov/pubmed/27716902 http://dx.doi.org/10.1002/cncr.30235 |
work_keys_str_mv | AT dollysaoirseo astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT kalaitzakieleftheria astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT puglisimartina astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT stimpsonsarah astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT hanwelljanet astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT fandossoniaserrano astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT stapletonsarah astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT ansarithushara astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT peckittclare astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT kayestan astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT lopezjuanita astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT yaptimothya astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT vandergraafwinette astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT debonojohann astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT banerjiudai astudyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT dollysaoirseo studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT kalaitzakieleftheria studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT puglisimartina studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT stimpsonsarah studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT hanwelljanet studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT fandossoniaserrano studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT stapletonsarah studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT ansarithushara studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT peckittclare studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT kayestan studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT lopezjuanita studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT yaptimothya studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT vandergraafwinette studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT debonojohann studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics AT banerjiudai studyofmotivationsandexpectationsofpatientsseeninphase1oncologyclinics |